2023 ABSTRACTING RESOURCES QUICK LINKS

  2023 DISEASE INDEX: https://seer.cancer.gov/tools/casefinding/

Jan 1, 2023 & forward, SEER has discontinued COVID19 data collection (page 21): 2023-Implementation-Guidelines_20220901.pdf

• Extent of Disease (EOD) General Instructions
• https://seer.cancer.gov/tools/staging/eod/
• Extent of Disease (EOD)
• https://staging.seer.cancer.gov/eod_public/home/3.0/
• SEER*RSA Staging Assistant
• https://staging.seer.cancer.gov/eod_public/stage/3.0/
• SEER Coding & Staging Manual 2023
• https://seer.cancer.gov/tools/codingmanuals/
• Solid Tumor Rules 2023
• https://seer.cancer.gov/tools/solidtumor/
• Grade Manual
• https://www.naaccr.org/wp-content/uploads/2022/10/Grade-Coding-Instructions-and-Tables-v3.pdf?v=1679583828
• Site Specific Data Items (SSDI)
• https://www.naaccr.org/wp-content/uploads/2023/02/Site-Specific-Data-Item-SSDI-Manual-v3_printed.pdf?v=1679583828
• STORE manual
• https://www.facs.org/quality-programs/cancer-programs/national-cancer-database/ncdb-call-for-data/registry-manuals/
• ICD-O-3 Coding Guidelines & Updates
• https://www.naaccr.org/icdo3/
• SEER Inquiry System / SINQ
• https://seer.cancer.gov/seer-inquiry/
• CAnswer Forum (AJCC, CoC, STORE, NAPBC, NAPRC)
• https://cancerbulletin.facs.org/forums/
• SEER Drug Database
• https://seer.cancer.gov/seertools/seerrx/
• SEER Hematopoietic & Lymphoid Neoplasm Database
• https://seer.cancer.gov/seertools/hemelymph/
• NPI Registry  / National Provider Identifier Physician Look Up
• https://npiregistry.cms.hhs.gov/search
• KCR Public Site
• https://www.kcr.uky.edu/
• Appendix C Site Groups
• Appendix C - Site Groups

Membership & Education

• National Cancer Registrars Association
• https://www.ncra-usa.org/ 
• CE Submission
• https://www.ncra-usa.org/Certification/RecertificationSubmission

INACCESSIBLE LYMPH NODE RULE

Page 23, Extent of Disease (EOD) 2018, General Coding Instructions (published October 2022):  https://seer.cancer.gov/tools/staging/eod/

RADIO-SENSITIZING CHEMOTHERAPY: If chemotherapy was provided as a radiosensitizer or radioprotectant DO NOT code as chemotherapy treatment. When chemotherapy is given for radiosensitization or radioprotection it is given in low doses that do not affect the cancer. Please review the treatment plan or reach out to the physicians administering treatment for confirmation.